INTERNATIONAL PATENT: ATOSSA THERAPEUTICS, INC., QUAY, STEVEN CARL FILES APPLICATION FOR "ENDOXIFEN FOR TREATMENT OF RARE CANCERS"

GENEVA, July 21 -- ATOSSA THERAPEUTICS, INC. (10202 5th Avenue NE, Suite 200Seattle, Washington 98125), QUAY, Steven Carl (c/o Atossa Therapeutics, Inc.10202 5th Avenue NE, Suite 200Seattle, Washington 98125) filed a patent application (PCT/US2025/010612) for "ENDOXIFEN FOR TREATMENT OF RARE CANCERS" on Jan 07, 2025. With publication no. WO/2025/151443, the details related to the patent application was published on Jul 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ATOSSA THERAPEUTICS, INC. (10202 5th Avenue NE, Suite 200Seattle, Washington 98125), QUAY, Steven Carl (c/o Atossa Therapeu...